Bortezomib TZF

Medicinal product

(Invented) name

Bortezomib TZF

Active substance (s)

Bortezomibas

Strength

3,5 mg

Pharmaceutical form

milteliai injekciniam tirpalui

Route (s) of administration

leisti į veną, leisti po oda

Legal status for supply

Receptinis

Narrow therapeutic index (NTI)

ATC code (s)

L01XG01, bortezomib

Marketing authorisation holder

Tarchomińskie Zakłady Farmaceutyczne „Polfa” Spółka Akcyjna, Lenkija

Date of authorisation

2023-10-13

Date of renewal

Documents

Stage

Registruotas

Controlled?

Controlled substance type

Legal basis

10(1)

Procedure number

PL/H/0860/001/DC

Marketing authorisation procedure

Decentralizuota procedūra

Qualitative and quantitative composition

Flakone yra:	1 vnt.
Bortezomibas	3,5 mg

Packages

PAKID	NPAKID	NPAKID-7	Pack type	Pack size	Type of packaging	Proposed dispensing/classification	Marketing authorisation no.	Supply status	From	To	Package is in foreign language	From	To	Mock-up
111791	97906	1097906	flakonas	N1		Receptinis	LT/1/23/5248/001	Netiekiama	-	-	No	-	-

Stadijos

Data	Stadija
2023-10-13	Registruotas